NHS to Offer New At-home Brain Cancer Treatment for Children

The new treatment targets specific genetic mutations in brain tumors, significantly extending progression-free survival.

The NHS in England will soon provide children with brain tumors a new at-home drug therapy targeting the BRAF V600E mutation.
Clinical trials show the treatment significantly reduces side effects and triples the progression-free survival time compared to traditional chemotherapy.
The treatment, combining dabrafenib and trametinib, can be administered at home, allowing children to maintain a better quality of life.
Around 180 children in the UK could benefit from this treatment annually, with significant improvements noted in both low-grade and high-grade gliomas.
Experts and patient advocates hail the treatment as a major advancement, offering hope for better outcomes and quality of life.